Depression and clinical progression in spinocerebellar ataxias - PubMed (original) (raw)

doi: 10.1016/j.parkreldis.2015.11.021. Epub 2015 Nov 22.

Karla P Figueroa 2, Stefan M Pulst 2, Susan Perlman 3, George Wilmot 4, Christopher Gomez 5, Jeremy Schmahmann 6, Henry Paulson 7, Vikram G Shakkottai 7, Sarah Ying 8, Theresa Zesiewicz 9, Khalaf Bushara 10, Michael Geschwind 11, Guangbin Xia 12, Jui-Tsen Yu 13, Lue-En Lee 13, Tetsuo Ashizawa 12, S H Subramony 12, Sheng-Han Kuo 14

Affiliations

Depression and clinical progression in spinocerebellar ataxias

Raymond Y Lo et al. Parkinsonism Relat Disord. 2016 Jan.

Abstract

Background: Depression is a common comorbidity in spinocerebellar ataxias (SCAs) but its association with ataxia progression is not well understood.

Objectives: To study the prevalence and influence of depressive symptoms in SCAs.

Methods: We studied 300 participants with SCA 1, 2, 3 and 6 from the Clinical Research Consortium for Spinocerebellar Ataxias (CRC-SCA) and repeatedly measured depressive symptoms by the 9-item Patient Health Questionnaire (PHQ-9) along with other clinical features including ataxia, functional status, and quality of life every 6 months for 2 years. We employed regression models to study the effects of depressive symptoms on clinical progression indexed by Scale for Assessment and Rating of Ataxia (SARA), Unified Huntington's Disease Rating Scale Part IV (UHDRS-IV) and EQ5D after adjusting for age, sex and pathological CAG repeats.

Results: Comorbid depression is common in SCAs (26%). Although the baseline prevalence of depression was similar among different SCA types, suicidal ideation was more frequently reported in SCA3 (65%). Depressive symptoms were associated with SARA scores but did not significantly progress over time within 2 years or deteriorate by increased numbers of pathological CAG repeats. The effects of depression on ataxia progression varied across different SCA types. Nevertheless, depression had consistently negative and significant impact on functional status and quality of life in all SCAs, even after accounting for ataxia progression.

Conclusions: Depressive symptoms are not simply the consequence of motor disability in SCAs. Comorbid depression per se contributes to different health outcomes and deserves more attention when caring patients with SCAs.

Keywords: Cerebellum; Depression; Neurodegeneration; Spinocerebellar ataxias; Suicide.

Copyright © 2015 Elsevier Ltd. All rights reserved.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Ashizawa T, Figueroa KP, Perlman SL, Gomez CM, Wilmot GR, Schmahmann JD, et al. Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study. Orphanet J Rare Dis. 2013;8:177. - PMC - PubMed
    1. Jacobi H, Bauer P, Giunti P, Labrum R, Sweeney MG, Charles P, et al. The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study. Neurology. 2011;77:1035–1041. - PMC - PubMed
    1. Moscovich M, Okun MS, Favilla C, Figueroa KP, Pulst SM, Perlman S, et al. Clinical evaluation of eye movements in spinocerebellar ataxias: a prospective multicenter study. J Neuroophthalmol. 2015;35:16–21. - PMC - PubMed
    1. Seidel K, Siswanto S, Brunt ER, den Dunnen W, Korf HW, Rüb U. Brain pathology of spinocerebellar ataxias. Acta Neuropathol. 2012;124:1–21. - PubMed
    1. Tezenas du Montcel S, Dürr A, Bauer P, Figueroa KP, Ichikawa Y, Brussino A, et al. Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes. Brain. 2014;137:2444–2455. - PMC - PubMed

Publication types

MeSH terms

Grants and funding

LinkOut - more resources